CyCa OncoSolutions Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $1.4M
Latest Deal Amount
  • Investors
  • 9

CyCa OncoSolutions General Information

Description

Developer of molecular devices designed to provide assistance in programmable delivery of anticancer drugs, antibiotics, and gene editing toolbox directly into the cells. The company's molecular devices cross the membrane bilayer and deliver functional molecules into the cytoplasm or other cellular organelles, enabling pharmaceutical and biotechnology companies to create new kind of anti-cancer drugs which may consist of increased brand lifecycle within them.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • The Rubicon Centre
  • CIT Campus, Bishopstown
  • Cork
  • Ireland
+353 089 000 0000

CyCa OncoSolutions Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CyCa OncoSolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Seed Round 08-Jun-2021 $1.4M 00.000 Completed Generating Revenue
7. Early Stage VC 31-Jul-2019 00000 Completed Generating Revenue
6. Grant 01-Jan-2019 000.00 00000 Completed Generating Revenue
5. Early Stage VC 25-Jul-2018 00000 Completed Generating Revenue
4. Grant 01-Jan-2018 00000 00000 Completed Startup
3. Grant 09-Dec-2017 0000 00000 Completed Startup
2. Accelerator/Incubator 10-May-2017 $320K $320K Completed Startup
1. Grant 01-Mar-2016 $69K Completed Startup
To view CyCa OncoSolutions’s complete valuation and funding history, request access »

CyCa OncoSolutions Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of molecular devices designed to provide assistance in programmable delivery of anticancer drugs, antibiotics,
Drug Delivery
Cork, Ireland
6 As of 2021
00.000
000000000 00.000

00000000

oluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pr
0000 000000000
San Francisco, CA
00 As of 0000
000.00
0000000000 0 000.00

00000000

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugi
0000000000000
Bedford, MA
000 As of 0000
00000
0000 0000-00-00
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CyCa OncoSolutions Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ligandal Venture Capital-Backed San Francisco, CA 00 000.00 0000000000 0 000.00
00000000 000000000 Formerly VC-backed Bedford, MA 000 00000 000000000 00000
0000000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
00000000 000 Formerly VC-backed Cambridge, MA 0000 00000 000000000 00000
000000000 Formerly VC-backed Paris, France 000 00000 00000000 00000
To view CyCa OncoSolutions’s complete competitors history, request access »

CyCa OncoSolutions Executive Team (6)

Name Title Board Seat Contact Info
Nusrat Sanghamitra Ph.D Co-Founder, Chief Executive Officer, CSO and Board Member
Saikh Krishnan Co-Founder & Board Member
Fazlul Krishan Co-Founder
Taiyyaba Kausar Co-Founder
William Liao Chairman
You’re viewing 5 of 6 executive team members. Get the full list »

CyCa OncoSolutions Board Members (3)

Name Representing Role Since
Fraser Stoddart Self Board Member 000 0000
Saikh Krishnan CyCa OncoSolutions Co-Founder & Board Member 000 0000
William Liao Self Chairman 000 0000
To view CyCa OncoSolutions’s complete board members history, request access »

CyCa OncoSolutions Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CyCa OncoSolutions Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sami Mikati Angel (individual) Minority 000 0000 000000 0
Sharaf Yamani Angel (individual) Minority 000 0000 000000 0
Voyagers.io Other Minority 000 0000 000000 0
Indian Department of Science and Technology Government 000 0000 000000 0
SOSV Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »